Françoise Brun-Vézinet

1953 -

kewarganegaraan: Prancis

bahasa tutur atau tulis: Prancis

penghargaan: Knight of the Legion of Honour

Françoise Brun-Vézinet est une virologue française qui a participé à la découverte du virus de l'immunodéficience humaine (VIH). Source: Wikipedia (fr)

Seri

There is nothing here

Create a new serie

Karya

There is nothing here

Create a new work

Artikel 320

Date

Judul

Pengarang

2020-04-01

[Viral reservoir in HIV-2 infection: a model for attenuated retroviral infection]

Françoise Brun-Vézinet
2020-08-13

Conventional Dendritic Cells and Slan+ Monocytes During HIV-2 Infection

Diane Descamps, Françoise Brun-Vézinet
2020-10-14

A comparison of cell activation, exhaustion and expression of HIV co-receptors and restriction factors in HIV-1 and HIV-2 infected Non Progressors

Françoise Brun-Vézinet
2019-05-16

Limited HIV-2 reservoirs in central-memory CD4 T-cells associated to CXCR6 co-receptor expression in attenuated HIV-2 infection

Assia Samri, Mariama Sadjo Diallo, Anne Hosmalin, Rémi Cheynier, Fideline Collin, Brigitte Autran, Françoise Brun-Vézinet, Christophe Parizot
2019-01-01

B7-H6-mediated downregulation of NKp30 in natural killer cells contributes to HIV-2 immune escape

Françoise Brun-Vézinet, Rodolphe Thiébaut, Vincent Vieillard, Patrice Debré
2018-03-24

First line raltegravir/emtricitabine/tenofovir combination in HIV-2 infection: phase 2 non-comparative trial (ANRS 159 HIV-2).

Gilles Peytavin, Geneviève Chêne, Diane Descamps, Charlotte Charpentier, Florence Damond, Roland Tubiana, Sophie Matheron, Emmanuel Mortier, Laurent Blum, Françoise Brun-Vézinet
2017-07-17

CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: a multinational, multicohort European study

Kholoud Porter, Jane Anderson, Vicente Soriano, Linda Wittkop, Dominique Costagliola, Gerd Fätkenheuer, Jürg Böni, Alexandra Calmy, François Dabis, Niels Obel, Ard van Sighem, Rodolphe Thiébaut, Robert Zangerle, Olivier Lambotte, Julie Arsandaux, Vitor Duque, Geneviève Chêne, Françoise Brun-Vézinet, Jean Ruel, Emília Valadas, Sophie Matheron, Catherine Leport
2016-08-26

Preservation of Lymphopoietic Potential and Virus Suppressive Capacity by CD8+ T Cells in HIV-2-Infected Controllers

Mathieu Angin, Sophie Matheron, Rémi Cheynier, Asier Sáez-Cirión, Laura Papagno, Charles Bayard, Amel Besseghir, Faroudy Boufassa, Gianfranco Pancino, Delphine Sauce, Sarah Rowland-Jones, Olivier Lambotte, Françoise Brun-Vézinet
2015-10-23

Contribution of APOBEC3G/F activity to the development of low-abundance drug-resistant human immunodeficiency virus type 1 variants

Marc Noguera-Julian, Roger Kouyos, Françoise Brun-Vézinet, Antonella d'Arminio Monforte
2015-04-01

High level of APOBEC3F/3G editing in HIV-2 DNA vif and pol sequences from antiretroviral-naive patients

Sophie Matheron, Françoise Brun-Vézinet, Lucile Larrouy, Diane Descamps, Charlotte Charpentier, Florence Damond, Alexandre Storto, Benoit Visseaux, Mélanie Bertine, ANRS CO5 HIV-2 Cohort
2015-07-17

HIV-2EU-Supporting Standardized HIV-2 Drug-Resistance Interpretation in Europe: An Update.

Françoise Brun-Vézinet, Martin Stürmer, Diane Descamps, Charlotte Charpentier, Jean Ruel, Lutz G Gürtler, Alejandro Pironti, Martin Obermeier, Rolf Kaiser
2015-08-06

Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates

Françoise Brun-Vézinet, Sophie Matheron, Gilles Peytavin, Diane Descamps, Charlotte Charpentier, Florence Damond, Benoit Visseaux, Mélanie Bertine, ANRS CO5 HIV-2 Cohort
2015-10-01

Tropism distribution among antiretroviral-naive HIV-2-infected patients

Sophie Matheron, Françoise Brun-Vézinet, Diane Descamps, Charlotte Charpentier, Florence Damond, Benoit Visseaux, ANRS CO5 HIV-2 Cohort, Suzon Drumard, Catherine Fagard, David Glohi
2014-09-01

HIV-2 X4 tropism is associated with lower CD4+ cell count in treatment-experienced patients

Sophie Matheron, Françoise Brun-Vézinet, Diane Descamps, Charlotte Charpentier, Florence Damond, Roland Tubiana, Benoit Visseaux, Catherine Fagard, David Glohi
2014-06-19

Virological outcome at week 48 of three recommended first-line regimens using ultrasensitive viral load and plasma drug assay

Françoise Brun-Vézinet, Gilles Peytavin, Diane Descamps, Charlotte Charpentier, Yazdan Yazdanpanah, Roland Landman, Benoit Visseaux, Patrick Yeni
2014-05-30

Comment on: Antiretroviral treatment French guidelines 2013: economics influencing science

Sophie Matheron, Isabelle Poizot-Martin, Christine Rouzioux, François Dabis, Françoise Brun-Vézinet
2014-05-01

Genotypic resistance profiles of HIV-2-treated patients in West Africa

Christine Rouzioux, Françoise Brun-Vézinet, Jean-christophe Plantier, Gilles Peytavin, François Dabis, Charlotte Charpentier, Florence Damond, Xavier Anglaret, Mélanie Bertine, Didier K Ekouevi, Albert Minga, IeDEA West Africa Collaboration, Serge Eholié, Veronique Avettand-Fenoel
2014-09-25

Lopinavir/r no longer recommended as a first-line regimen: a comparative effectiveness analysis

Isabelle Poizot-Martin, Dominique Costagliola, Françoise Brun-Vézinet
2014-10-21

Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case-control study using centralized ultrasensitive 454 pyrosequencing

Francesca Ceccherini-Silberstein, Alessandro Cozzi-Lepri, Antonella d'Arminio Monforte, Martin Däumer, Marc Noguera-Julian, Francesca Di Giallonardo, Karin J Metzner, Roger Kouyos, Huldrych F Günthard, Hansjakob Furrer, Bernard Masquelier, Roger Paredes, Françoise Brun-Vézinet, Rolf Kaiser
2013-06-01

Antiretroviral treatments in 2012: improvements and future prospects

Françoise Brun-Vézinet
2013-11-01

In-vitro phenotypic susceptibility of HIV-1 'non-B' integrase inhibitors naive clinical isolates to dolutegravir and raltegravir

Françoise Brun-Vézinet, Lucile Larrouy, Gilles Peytavin, Diane Descamps, Charlotte Charpentier, Benoit Visseaux, Mélanie Bertine, Juliette Leleu, Thomas Mourez
2013-01-01

Impact of gag genetic determinants on virological outcome to boosted lopinavir-containing regimen in HIV-2-infected patients

Sophie Matheron, Alexandre Vivot, Lucile Larrouy, Diane Descamps, Charlotte Charpentier, Florence Damond, Françoise Brun-Vézinet, Antoine Benard, Benoit Visseaux, ANRS CO5 HIV-2 Cohort, Geneviève Chêne
2013-06-05

Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network.

Carlo Federico Perno, Bonaventura Clotet Sala, Deenan Pillay, Jan Albert, Françoise Brun-Vézinet
2013-01

Concordance between HIV-2 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA

Sophie Matheron, Françoise Brun-Vézinet, Lucile Larrouy, Diane Descamps, Geneviève Chêne, Charlotte Charpentier, Florence Damond, Antoine Benard, Benoit Visseaux, Audrey Taieb
2013-06-24

National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011.

Anne-Geneviève Marcelin, Françoise Brun-Vézinet, Dominique Costagliola, Alexis de Rougemont, Jean-christophe Plantier, ANRS AC11 Resistance Study Group, Diane Descamps, Jacques Izopet, Charlotte Charpentier, Stéphanie Raymond, Constance Delaugerre, Marc Wirden, Marie-Laure Chaix, Alexandre Storto, Catherine Tamalet, Jacqueline Cottalorda, Cécile Henquell, Bernard Masquelier, Brigitte Montes, Delphine Desbois, Coralie Pallier, Lambert Assoumou, Sophie Pakianather, Anne Krivine, Anne M Maillard, Laurence Morand-Joubert
2013-01-17

Role of baseline HIV-1 DNA level in highly-experienced patients receiving raltegravir, etravirine and darunavir/ritonavir regimen (ANRS139 TRIO trial).

Christine Katlama, Françoise Brun-Vézinet, Geneviève Chêne, Diane Descamps, Charlotte Charpentier, Yazdan Yazdanpanah, Anne-Marie Taburet, Jean-Michel Molina, Benoit Visseaux, Catherine Fagard, Céline Colin, Christine Jacomet
2013-01-18

Description of the L76V resistance protease mutation in HIV-1 B and "non-B" subtypes

Francesca Ceccherini-Silberstein, Anne-Geneviève Marcelin, Sidonie Lambert-Niclot, Françoise Brun-Vézinet, Claudia Alteri, Philippe Flandre, Diane Descamps, Charlotte Charpentier, Alexandre Storto, Valentina Svicher, Carlo Federico Perno
2013-03-19

Predictive value of liver enzymes and inflammatory biomarkers for the severity of liver fibrosis stage in HIV/HCV co-infected patients

Françoise Brun-Vézinet, Lucile Larrouy, Diane Descamps, Charlotte Charpentier, Florence Damond, Yazdan Yazdanpanah, Karen Champenois, Anne Gervais, Roland Landman, Sylvie Le Gac
2013-06-01

Transmitted drug resistance in French HIV-2-infected patients

Françoise Brun-Vézinet, Geneviève Chêne, Sophie Matheron, Gilles Peytavin, Diane Descamps, Charlotte Charpentier, Florence Damond, Antoine Benard, Benoit Visseaux, ANRS CO5 HIV-2 Cohort, Audrey Taieb
2013-06-01

Oral antiretroviral drugs as public health tools for HIV prevention: global implications for adherence, drug resistance, and the success of HIV treatment programs

Anders Sönnerborg, Mark Wainberg, Jan Albert, Françoise Brun-Vézinet
2013-02-19

HIV-2EU: supporting standardized HIV-2 drug resistance interpretation in Europe

Françoise Brun-Vézinet, Martin Stürmer, Ricardo Camacho, Diane Descamps, Charlotte Charpentier, Jean Ruel, Lutz G Gürtler, Alejandro Pironti, Martin Obermeier, Rolf Kaiser
2013-04-28

Update on the human immunodeficiency virus

Françoise Brun-Vézinet

Human - wd:Q3086421

Selamat datang di Inventaire

perpustakaan teman-teman dan komunitas anda

pelajari lebih lanjut